[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for…
Tag:
Autoimmune Diseases
-
-
STOCK MARKET
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
by userby user[ad_1] After surviving some turbulent market conditions in its first years as a public company,…
-
[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday,…